Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Clinigen Healthcare Ltd., Pitcairn House, First Avenue, Burton-on-Trent, Staffordshire, DE14 2WW, UK
Foscavir 24 mg/ml Solution for Infusion.
| Pharmaceutical Form |
|---|
|
Solution for infusion. Clear and colourless solution. |
Foscarnet trisodium hexahydrate 24 mg/ml.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Foscarnet |
Foscarnet is an antiviral agent with a broad spectrum inhibiting all known human viruses of the herpes group. Foscarnet exerts its antiviral activity by a direct inhibition of viral specific DNA polymerase a reverse transcriptase at concentrations that do not affect cellular DNA polymerases. |
| List of Excipients |
|---|
|
Water for injection |
Infusion glass bottles of 250 ml.
Clinigen Healthcare Ltd., Pitcairn House, First Avenue, Burton-on-Trent, Staffordshire, DE14 2WW, UK
PL 31644/0001
10/06/2010
| Drug | Countries | |
|---|---|---|
| FOSCAVIR | Estonia, Spain, France, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Singapore, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
